Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Jun 2018 | Jun 2017 | ||
---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||
Cost of Revenue | ||||||||
Gross Profit | ||||||||
Gross Profit Margin (%) | ||||||||
R&D Expense | ||||||||
SG&A Expense | ||||||||
Total Operating Expenses | ||||||||
Operating Income or Loss | ||||||||
Operating Margin (%) | ||||||||
Interest Expense | ||||||||
Total Other Income/Expenses | ||||||||
Income Before Tax | ||||||||
Income Tax Expense | ||||||||
Income from Continuing Ops. | ||||||||
Net Income | ||||||||
Net Profit Margin (%) | ||||||||
Net Income Available to Common Shareholders | ||||||||
Basic EPS | ||||||||
Diluted EPS | ||||||||
Basic Average Shares | ||||||||
Diluted Average Shares |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Jan 2017 | Oct 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||||
Cost of Revenue | |||||||||||||||
Gross Profit | |||||||||||||||
Gross Profit Margin (%) | |||||||||||||||
R&D Expense | |||||||||||||||
SG&A Expense | |||||||||||||||
Total Operating Expenses | |||||||||||||||
Operating Income or Loss | |||||||||||||||
Operating Margin (%) | |||||||||||||||
Interest Expense | |||||||||||||||
Total Other Income/Expenses | |||||||||||||||
Income Before Tax | |||||||||||||||
Income Tax Expense | |||||||||||||||
Income from Continuing Ops. | |||||||||||||||
Net Income | |||||||||||||||
Net Profit Margin (%) | |||||||||||||||
Net Income Available to Common Shareholders | |||||||||||||||
Basic EPS | |||||||||||||||
Diluted EPS | |||||||||||||||
Basic Average Shares | |||||||||||||||
Diluted Average Shares |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Jun 2018 | Jun 2017 | ||
---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||
Cash & Cash Equivalents | ||||||||
Marketable Securities | ||||||||
Receivables | ||||||||
Inventories | ||||||||
Other Current Assets | ||||||||
Total Current Assets | ||||||||
Non-Current Assets | ||||||||
Marketable Securities | ||||||||
PPE Net | ||||||||
Intangibles inc. Goodwill | ||||||||
Other Non-Current Assets | ||||||||
Total Non-Current Assets | ||||||||
Total Assets | ||||||||
Current Liabilities | ||||||||
Accounts Payable | ||||||||
Deferred Revenues | ||||||||
Debt, Current | ||||||||
Accrued Liabilities | ||||||||
Other Current Liabilities | ||||||||
Total Current Liabilities | ||||||||
Non-Current Liabilities | ||||||||
Deferred Revenues | ||||||||
Debt, Non-Current | ||||||||
Other Non-Current Liabilities | ||||||||
Total Non-Current Liabilities | ||||||||
Total Liabilities | ||||||||
Shareholders' Equity | ||||||||
Common Stock | ||||||||
Additional Paid-In Capital | ||||||||
Retained Earnings | ||||||||
Other Shareholders' Equity | ||||||||
Total Shareholders' Equity | ||||||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Jan 2017 | Oct 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||||
Cash & Cash Equivalents | |||||||||||||||
Marketable Securities | |||||||||||||||
Receivables | |||||||||||||||
Inventories | |||||||||||||||
Other Current Assets | |||||||||||||||
Total Current Assets | |||||||||||||||
Non-Current Assets | |||||||||||||||
Marketable Securities | |||||||||||||||
PPE Net | |||||||||||||||
Intangibles inc. Goodwill | |||||||||||||||
Other Non-Current Assets | |||||||||||||||
Total Non-Current Assets | |||||||||||||||
Total Assets | |||||||||||||||
Current Liabilities | |||||||||||||||
Accounts Payable | |||||||||||||||
Deferred Revenues | |||||||||||||||
Debt, Current | |||||||||||||||
Accrued Liabilities | |||||||||||||||
Other Current Liabilities | |||||||||||||||
Total Current Liabilities | |||||||||||||||
Non-Current Liabilities | |||||||||||||||
Deferred Revenues | |||||||||||||||
Debt, Non-Current | |||||||||||||||
Other Non-Current Liabilities | |||||||||||||||
Total Non-Current Liabilities | |||||||||||||||
Total Liabilities | |||||||||||||||
Shareholders' Equity | |||||||||||||||
Common Stock | |||||||||||||||
Additional Paid-In Capital | |||||||||||||||
Retained Earnings | |||||||||||||||
Other Shareholders' Equity | |||||||||||||||
Total Shareholders' Equity | |||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Jun 2018 | Jun 2017 | ||
---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||
Net Income | ||||||||
Depreciation & Amortization | ||||||||
Deferred Income Taxes | ||||||||
Stock Based Compensation | ||||||||
Accounts Receivable | ||||||||
Inventory | ||||||||
Accounts Payable | ||||||||
Deferred Revenue | ||||||||
Other Non-Cash | ||||||||
Operating Cash Flow | ||||||||
Cash Flows from Investing Activities | ||||||||
PPE Investments | ||||||||
Net Acquisitions | ||||||||
Purchase of Investments | ||||||||
Sale of Investments | ||||||||
Other Investing Activity | ||||||||
Investing Cash Flow | ||||||||
Cash Flows from Financing Activities | ||||||||
Debt Issued | ||||||||
Proceeds from Debt Repayment | ||||||||
Debt Repayment | ||||||||
Proceeds from Sale of Equity | ||||||||
Equity Repurchased | ||||||||
Dividend Paid | ||||||||
Other Financing Activity | ||||||||
Financing Cash Flow | ||||||||
Cash Position | ||||||||
Beginning Cash Position | ||||||||
End Cash Position | ||||||||
Change in Cash | ||||||||
Free Cash Flow | ||||||||
Operating Cash Flow | ||||||||
Capital Expenditure | ||||||||
Free Cash Flow |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Jan 2017 | Oct 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||||
Net Income | |||||||||||||||
Depreciation & Amortization | |||||||||||||||
Deferred Income Taxes | |||||||||||||||
Stock Based Compensation | |||||||||||||||
Accounts Receivable | |||||||||||||||
Inventory | |||||||||||||||
Accounts Payable | |||||||||||||||
Deferred Revenue | |||||||||||||||
Other Non-Cash | |||||||||||||||
Operating Cash Flow | |||||||||||||||
Cash Flows from Investing Activities | |||||||||||||||
PPE Investments | |||||||||||||||
Net Acquisitions | |||||||||||||||
Purchase of Investments | |||||||||||||||
Sale of Investments | |||||||||||||||
Other Investing Activity | |||||||||||||||
Investing Cash Flow | |||||||||||||||
Cash Flows from Financing Activities | |||||||||||||||
Debt Issued | |||||||||||||||
Proceeds from Debt Repayment | |||||||||||||||
Debt Repayment | |||||||||||||||
Proceeds from Sale of Equity | |||||||||||||||
Equity Repurchased | |||||||||||||||
Dividend Paid | |||||||||||||||
Other Financing Activity | |||||||||||||||
Financing Cash Flow | |||||||||||||||
Cash Position | |||||||||||||||
Beginning Cash Position | |||||||||||||||
End Cash Position | |||||||||||||||
Change in Cash | |||||||||||||||
Free Cash Flow | |||||||||||||||
Operating Cash Flow | |||||||||||||||
Capital Expenditure | |||||||||||||||
Free Cash Flow |